Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy-negative individuals
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
The mRNA for the Duffy blood group antigen, the erythrocyte receptor for the Plasmodium vivax malaria parasite, has recently been cloned and shown to encode a widely expressed chemokine receptor. Here, we show that the Duffy antigen/chemokine receptor gene (DARC) is composed of a single exon and that most Duffy-negative blacks carry a silent FY*B allele with a single T to C substitution at nucleotide -46. This mutation impairs the promoter activity in erythroid cells by disrupting a binding site for the GATA1 erythroid transcription factor. With the recent characterization of the FY*A and FY*B alleles, these findings provide the molecular basis of the Duffy blood group system and an explanation for the erythroid-specific repression of the DARC gene in Duffy-negative individuals.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“DARC is an atypical chemokine receptor and the antigen of the Duffy (Fy) blood group system (Tournamille et al., 1995; Tournamille et al., 1998; Wasniowska and Hadley, 1994).”
From Staphylococcus aureus Targets the Duffy Antigen Receptor for Chemokines (DARC) to Lyse Erythrocytes (2015) · cites this paper as Tournamille et al., 1995
In the citing paper
“A substantial part of the human population carries a homozygous mutation (FY*AES or FY*BES alleles for erythrocyte silent) in the erythroid-specific promoter of the FY gene, resulting in a lack of expression of the receptor on erythrocytes (Fya−/b− phenotype) but not in non-erythroid tissues (Tournamille et al., 1995; Zimmerman et al., 1999).”
From Staphylococcus aureus Targets the Duffy Antigen Receptor for Chemokines (DARC) to Lyse Erythrocytes (2015) · cites this paper as Tournamille et al., 1995
Citations
Cites
Luckow, B., & Schütz, G. (1987) · Nucleic Acids Research · doi:10.1093/nar/15.13.5490 · Cited by 1,701
MODEL SYSTEMS FOR THE STUDY OF SEVEN-TRANSMEMBRANE-SEGMENT RECEPTORS
Dohlman, H. G., Thorner, J., Caron, M. G., & Lefkowitz, R. J. (1991) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.60.070191.003253 · Cited by 1,379
The Resistance Factor to Plasmodium vivax in Blacks: The Duffy-Blood-Group Genotype,FyFy
Miller, L. H., Mason, S. J., Clyde, D. F., & McGinniss, M. H. (1976) · New England Journal of Medicine · doi:10.1056/nejm197608052950602 · Cited by 1,260
Race, R. R., & Sanger, R. A. (1962) · Medical Entomology and Zoology · Cited by 1,162
Compilation of vertebrate-encoded transcription factors
Faisst, S., & Meyer, S. (1992) · Nucleic Acids Research · doi:10.1093/nar/20.1.3 · Cited by 914
GATA-binding transcription factors in hematopoietic cells
Orkin, S. (1992) · Blood · doi:10.1182/blood.v80.3.575.575 · Cited by 884
Erythrocyte Receptors for ( Plasmodium Knowlesi ) Malaria: Duffy Blood Group Determinants
Miller, L. H., Mason, S. J., Dvorak, J. A., McGinniss, M. H., & Rothman, I. K. (1975) · Science · doi:10.1126/science.1145213 · Cited by 610
Red blood cells are a sink for interleukin 8, a leukocyte chemotaxin.
Darbonne, W. C., Rice, G. C., Mohler, M. A., Apple, T., Hébert, C. A., Valente, A. J., & Baker, J. B. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115442 · Cited by 452
Globin gene regulation and switching: Circa 1990
Orkin, S. H. (1990) · Cell · doi:10.1016/0092-8674(90)90133-y · Cited by 442
Chitnis, C. E., & Miller, L. H. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.2.497 · Cited by 426
Research works printed but not linked: 1
- Toumamilte, C., Le Van Kim, C., Gane, P., Cartron, J.P. & Colin, Y. Molecular basis and PCR-DNA typing of the Pya/Pyb blood group polymorphism. Hum. Genet. 85, 407–410 (1995).
Cited by
Items 101–200 of 742
Convergent gene losses illuminate metabolic and physiological changes in herbivores and carnivores
Hecker, N., Sharma, V., & Hiller, M. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1818504116 · Cited by 115
“One such case is a promoter mutation in human populations in the DARC gene, which protects from infection with the malaria parasite Plasmodium (49).”
BackgroundVivax malaria in Mauritania includes infection of a Duffy-negative individual
Wurtz, N., Lekweiry, K. M., Bogreau, H., Pradines, B., Rogier, C., Boukhary, A. O. M. S., Hafid, J. E., Salem, M. S. O. A., Trape, J., Basco, L. K., et al. (2011) · Malaria Journal · doi:10.1186/1475-2875-10-336 · Cited by 116
“Duffy expression is disrupted by a T to C substitution in the gene’s promoter region at nucleotide -33, preventing the binding of the h-GATA-1 erythroid transcription factor and resulting in the null expression of the Duffy gene in erythroid cells only [38-40].”
BackgroundMcManus, K. F., Oill, A. M. T., Henn, B. M., Bustamante, C. D., Sikora, M., & Cornejo, O. E. (2017) · PLoS Genetics · doi:10.1371/journal.pgen.1006560 · Cited by 141
“Of the three allelic types, FY A and FY B are functional proteins, while FY O does not express the protein on erythrocyte surfaces due to a mutation in the promoter region, which causes erythroid-specific suppression of gene expression [6, 10].”
BackgroundStaphylococcus aureus Targets the Duffy Antigen Receptor for Chemokines (DARC) to Lyse Erythrocytes
Spaan, A. N., Reyes-Robles, T., Badiou, C., Cochet, S., Boguslawski, K. M., Yoong, P., Day, C. J., de Haas, C. J. C., van Kessel, K. P. M., Vandenesch, F., et al. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.08.001 · Cited by 114
“…a homozygous mutation (FY*AES or FY*BES alleles for erythrocyte silent) in the erythroid-specific promoter of the FY gene, resulting in a lack of expression of the receptor on erythrocytes (Fya−/b− phenotype) but not in non-erythroid tissues (Tournamille et al., 1995; Zimmerman et al., 1999).”
BackgroundSelf-citationDual targeting of CCR2 and CCR5: therapeutic potential for immunologic and cardiovascular diseases
Zhao, Q. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.1009671 · Cited by 121
“of the Duffy antigen receptor for chemokines [10, 11].”
BackgroundStructural and functional diversity of blood group antigens
Cartron, J., & Colin, Y. (2001) · Transfusion Clinique et Biologique · doi:10.1016/s1246-7820(01)00142-2 · Cited by 113
Self-citationThe molecular genetics of blood group polymorphism
Daniels, G. L. (2009) · Human Genetics · doi:10.1007/s00439-009-0738-2 · Cited by 129
“the erythroid-speciWc GATA-1 transcription factor: ¡67T>C converting the TTATCT GATA-1 binding site consensus sequence to TTACCT (Tournamille et al. 1995) (Table 5).”
BackgroundThe molecular signature of selection underlying human adaptations
Harris, E. E., & Meyer, D. (2006) · American Journal of Physical Anthropology · doi:10.1002/ajpa.20518 · Cited by 111
“Aspartic acid) at codon 44 that accounts for the difference between the FY*A and FY*B alleles (Tournamille et al., 1995).”
BackgroundInsights into the Structure and Function of Membrane Polypeptides Carrying Blood Group Antigens
Cartron, J., Bailly, P., Kim, C. L. V., Chérif‐Zahar, B., Matassi, G., Bertrand, O., & Colin, Y. (1998) · Vox Sanguinis · doi:10.1111/j.1423-0410.1998.tb05397.x · Cited by 110
Self-citationRole of SCN5A Y1102 Polymorphism in Sudden Cardiac Death in Blacks
Burke, A., Creighton, W., Mont, E., Li, L., Hogan, S., Kutys, R., Fowler, D., & Virmani, R. (2005) · Circulation · doi:10.1161/circulationaha.104.482760 · Cited by 118
Langhi, D. M., & Bordin, J. O. (2006) · Hematology · doi:10.1080/10245330500469841 · Cited by 114
“Since the molecular basis of the Duffy blood group polymorphisms has been determined, the molecular mechanism that gives rise to the phenotype Fy(a - b - ) in black individuals has been classically associated with a point mutation - 33TC in the promoter region of a FY* B allele, a mutation that when present in homozyg…”
BackgroundInfluentialHuman genetics of infectious diseases: Unique insights into immunological redundancy
Casanova, J.-L., & Abel, L. (2018) · Seminars in Immunology · doi:10.1016/j.smim.2017.12.008 · Cited by 104
Susceptibility to malaria as a complex trait: big pressure from a tiny creature
Fortin, A. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.20.2469 · Cited by 104
“A variant polymorphism at a GATA-1binding site in the promoter of the DARC gene alters receptor expression and thereby prevents parasite entry (42).”
BackgroundBlood groups: the past 50 years
Daniels, G. L., & Reid, M. E. (2009) · Transfusion · doi:10.1111/j.1537-2995.2009.02456.x · Cited by 124
Chemokines on the move: control by the chemokine “interceptors” Duffy blood group antigen and D6
Nibbs, R. J. B., Graham, G. J., & Rot, A. (2003) · Seminars in Immunology · doi:10.1016/j.smim.2003.08.006 · Cited by 117
Evidence for Hitchhiking of Deleterious Mutations within the Human Genome
Chun, S., & Fay, J. C. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002240 · Cited by 103
“Although some of these regions include multiple duplicated genes, which could explain the large number of SNPs predicted to be deleterious, one of the regions includes a gene thought to have been under selection, DARC [53], and many of the regions contain deleterious SNPs in genes with disparate functions.”
Host Genes and HIV: The Role of the Chemokine Receptor Gene CCR5 and Its Allele (∆32 CCR5)
McNicholl, J. M., Smith, D. K., Qari, S. H., & Hodge, T. W. (1997) · Emerging infectious diseases · doi:10.3201/eid0303.970302 · Cited by 120
“vivax malaria is associated with lack of DARC expression (29), probably due to polymorphism of the DARC gene promoter (30).”
Gunalan, K., Niangaly, A., Thera, M. A., Doumbo, O. K., & Miller, L. H. (2018) · Trends in Parasitology · doi:10.1016/j.pt.2018.02.006 · Cited by 101
Deletion of the Murine Duffy Gene ( Dfy ) Reveals that the Duffy Receptor Is Functionally Redundant
Luo, H., Chaudhuri, A., Zbrzezna, V., He, Y., & Pogo, A. O. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.9.3097-3101.2000 · Cited by 101
“They are healthy individuals who carry a mutation in the promoter region of FY that disrupts the binding site for h-GATA-1 erythroid transcription factor and abolishes expression of FY in erythroid but not nonerythroid cells (29).”
Krishnan, P., Meile, L., Plissonneau, C., Ma, X., Hartmann, F. E., Croll, D., McDonald, B. A., & Sánchez‐Vallet, A. (2018) · BMC Biology · doi:10.1186/s12915-018-0543-2 · Cited by 103
Olsson, M. L., Smythe, J. S., Hansson, C., Poole, J., Mallinson, G., Jones, J. W., Avent, N. D., & Daniels, G. L. (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.01083.x · Cited by 115
“The molecular defect responsible for the inactivation of the silent alleles among Blacks was shown to be a single T → C nt substitution in the FY promoter region (Tournamille et al, 1995a; Iwamoto et al, 1995a).”
BackgroundRed Blood Cell Polymorphism and Susceptibility to Plasmodium vivax
Zimmerman, P. A., Ferreira, M. U., Howes, R. E., & Mercereau‐Puijalon, O. (2013) · Advances in Parasitology/Advances in parasitology · doi:10.1016/b978-0-12-407826-0.00002-3 · Cited by 122
Genetic control of resistance to human malaria
ALLISON, A. C. (2009) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.04.001 · Cited by 114
Knight, J. C. (2003) · Clinical Science · doi:10.1042/cs20020304 · Cited by 111
“In Duffy-negative individuals, a T ! C SNP in the DARC promoter region results in erythroidspecific repression of gene expression [ 5 ].”
Sirugo, G., Hennig, B. J., Adeyemo, A., Matimba, A., Newport, M. J., Ibrahim, M. E., Ryckman, K. K., Tacconelli, A., Mariani‐Costantini, R., Novelli, G., et al. (2008) · Human Genetics · doi:10.1007/s00439-008-0511-y · Cited by 105
“The lack of DuVy expression is due to a promoter SNP that alters a binding site for the GATA-1 transcription factor (Tournamille et al. 1995), resulting in the parasite being unable to invade red blood cells.”
BackgroundParasol, N., Reid, M. E., Rios, M., Castilho, L. M., Harari, I., & Kosower, N. S. (1998) · Blood · doi:10.1182/blood.v92.7.2237 · Cited by 95
Segerer, S., Regele, H. M., Mack, M., Kain, R., Cartron, J., Colin, Y., Kerjaschki, D., & Schlöndorff, D. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00316.x · Cited by 95
Self-citationSignificant Admixture Linkage Disequilibrium across 30 cM around the FY Locus in African Americans
Lautenberger, J. A., Stephens, J. C., O’Brien, S. J., & Smith, M. W. (2000) · The American Journal of Human Genetics · doi:10.1086/302820 · Cited by 99
“Polymorphisms in the human AT3 gene that were due to the presence of 32- or 108-bp nonhomologous DNA (Bock and Levitan 1983; Wu et al. 1989), the STR loci (Hentati et al. 1992; Dib et al. 1996), and the FY poly- morphism (Tournamille et al. 1995; Iwamoto et al. 1996) were assayed (table 1).”
MethodRed blood cell alloimmunization in sickle cell disease: prevalence in 2010
Miller, S. T., Kim, H., Weiner, D. L., Wager, C. G., Gallagher, D. M., Styles, L. A., Dampier, C., & Roseff, S. D. (2012) · Transfusion · doi:10.1111/j.1537-2995.2012.03796.x · Cited by 102
“36,37 The SCDCRN had hoped to assess the potential therapeutic impact of transfusion of Duffy positive cells as a secondary endpoint but failed to accrue adequate numbers of transfused patients.”
BackgroundOlsson, M. L., Hansson, C., Avent, N. D., Akesson, I. E., Green, C. A., & Daniels, G. L. (1998) · Transfusion · doi:10.1046/j.1537-2995.1998.38298193099.x · Cited by 106
Mbenda, H. G. N., & Das, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103262 · Cited by 100
“This approach relies on the fact that finding the C nucleotide in a single peak in the DNA chromatogram at the -33 position specifies complete Duffy-negative status (also known as FY*O homozygote genotype), meaning no expression of the Duffy protein on the erythrocytes [31].”
BackgroundGenetic susceptibility to malaria getting complex
Kwiatkowski, D. P. (2000) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(00)00087-3 · Cited by 93
A History of Recurrent Positive Selection at the Toll-Like Receptor 5 in Primates
Wlasiuk, G., Khan, S., Switzer, W. M., & Nachman, M. W. (2009) · Molecular Biology and Evolution · doi:10.1093/molbev/msp018 · Cited by 93
“This idea has received considerable attention recently in light of several reports of adaptive pseudogenizations in the human lineage (Tournamille et al. 1995; Ali et al. 1998; Wang et al. 2006; Seixas et al. 2007).”
Cavasini, C. E., de Mattos, L. C., Couto, Á. A. D., Couto, V. S. C. D., Gollino, Y., Moretti, L. J., Bonini-Domingos, C. R., Rossit, A. R. B., Castilho, L. M., & Machado, R. L. D. (2007) · Malaria Journal · doi:10.1186/1475-2875-6-167 · Cited by 92
Role of Plasmodium vivax Duffy-binding protein 1 in invasion of Duffy-null Africans
Gunalan, K., Lo, E. Y. Y., Hostetler, J. B., Yewhalaw, D., Mu, J., Neafsey, D. E., Yan, G., & Miller, L. H. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1606113113 · Cited by 90
“vivax-positive samples, an ∼500-bp fragment of the human Duffy blood group antigen gene that encompasses the −33rd nucleotide position located in the GATA1 transcription factor-binding site of the gene promoter was amplified and sequenced following published protocols (5, 50).”
BackgroundMethodMolecular mechanisms that lead to reduced expression of Duffy antigens
Yazdanbakhsh, K., Rios, M., Storry, J. R., Kosower, N. S., Parasol, N., Chaudhuri, A., & Reid, M. E. (2000) · Transfusion · doi:10.1046/j.1537-2995.2000.40030310.x · Cited by 96
Science, medicine, and the future: Susceptibility to infection
Kwiatkowski, D. (2000) · BMJ · doi:10.1136/bmj.321.7268.1061 · Cited by 89
Chakera, A., Seeber, R. M., John, A. E., Eidne, K. A., & Greaves, D. R. (2008) · Molecular Pharmacology · doi:10.1124/mol.107.040915 · Cited by 88
“That individuals in areas prone to Plasmodium vivax malaria have developed erythroid-specific promoter mutations that abolish expression of DARC on red blood cells, yet retain expression of DARC in other tissues argues for an important physiological role for DARC (Tournamille et al., 1995; Zimmerman et al., 1999).”
BackgroundGenetic variability in response to infection: malaria and after
Weatherall, D. J., & Clegg, J. B. (2002) · Genes and Immunity · doi:10.1038/sj.gene.6363878 · Cited by 94
Failure to detect Plasmodium vivax in West and Central Africa by PCR species typing
Culleton, R. L., Mita, T., Ndounga, M., Unger, H. W., Cravo, P., Paganotti, G. M., Takahashi, N., Kaneko, A., Eto, H., Tinto, H., et al. (2008) · Malaria Journal · doi:10.1186/1475-2875-7-174 · Cited by 90
“Duffy negative individuals are homozygous for a DARC allele, FY*Bnull, which carries a single nucleotide mutation which impairs promoter activity by disrupting a binding site for the h-GATA-1 erythroid transcription factor [7].”
BackgroundIwamoto, S., Li, J., Omi, T., Ikemoto, S., & Kajii, E. (1996) · Blood · doi:10.1182/blood.v87.1.378.378 · Cited by 87
Cavaillès, P., Sergent, V., Bisanz, C., Papapietro, O., Colacios, C., Mas, M., Subra, J.-F., Lagrange, D., Calise, M., Appolinaire, S., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506643103 · Cited by 86
Mangano, A. M., Gonzalez, E., Dhanda, R., Catano, G., Bamshad, M., Bock, A., Duggirala, R., Williams, K., Mummidi, S., Clark, R. A., et al. (2001) · The Journal of Infectious Diseases · doi:10.1086/320705 · Cited by 90
“Notably, there is strong precedence linking genetic variation in the cis-regulatory regions of genes and pathogenesis of infectious diseases [75, 76].”
BackgroundReduced Plasmodium vivax Erythrocyte Infection in PNG Duffy-Negative Heterozygotes
Kasehagen, L. J., Müeller, I., Kiniboro, B., Bockarie, M. J., Reeder, J. C., Kazura, J. W., Kastens, W., McNamara, D. T., King, C. H., Whalen, C. C., et al. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000336 · Cited by 82
“A single nucleotide polymorphism (SNP) in the Duffy gene (FY) corrupts the GATA-1 transcription factor binding site regulating erythroid Duffy antigen expression specifically (233 TRC [22]; numbering based on Iwamoto et al., 1996 [23]).”
BackgroundThe Population Genetics and Dynamics of the Thalassemias
Weatherall, D. J., Williams, T. N., Allen, S. J., & O’Donnell, A. (2010) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2010.08.010 · Cited by 83
Lee, J. S., Wurfel, M. M., Matute‐Bello, G., Frevert, C. W., Rosengart, M. R., Ranganathan, M., Wong, V. W., Holden, T. D., Sutlief, S. G., Richmond, A. J., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.11.8086 · Cited by 88
“The selective abrogation of erythrocyte Duffy Ag is due to a substitution T-46C in the GATA-1 erythroid-specific promoter region of the Duffy gene (17).”
BackgroundChanging practice: red blood cell typing by molecular methods for patients with sickle cell disease
Casas, J. A., Friedman, D. F., Jackson, T., Vege, S., Westhoff, C. M., & Chou, S. T. (2015) · Transfusion · doi:10.1111/trf.12987 · Cited by 82
“The assay also identifies the T>C substitution in the FY erythroid promoter that disrupts binding of the GATA1 erythroid transcription factor and results in RBC-specific loss of Fy antigen expression.(21) The RBC genotype of 410 patients (83%) was predicted to be Fy–, but 404 (98.”
BackgroundImpact of race/ethnicity on molecular pathways in human cancer
Wiencke, J. K. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1257 · Cited by 81
“cgi?l=2623">GATA1 , leading to loss of Duffy expressio”
BackgroundAfenyi‐Annan, A., Kail, M. E., Combs, M. R., Orringer, E. P., Ashley‐Koch, A. E., & Telen, M. J. (2008) · Transfusion · doi:10.1111/j.1537-2995.2007.01622.x · Cited by 135
“In this population, the Fy(a–b–) phenotype is determined by a mutation in the promoter region of the FY gene that abolishes activity of a GATA site necessary for gene transcription in erythroid cells.(21) Duffy antigens are expressed by both erythroid cells and nonerythroid cells, including brain endothelial cells and…”
BackgroundNovitzky‐Basso, I., & Rot, A. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00266 · Cited by 81
“…at nucleotide −67 within the erythroid GATA-1 promoter region, 33 bp upstream from the erythroid transcription starting point and 46 bp upstream from the start of the major transcript translation codon, thus preventing DARC transcription in erythroid cells only (Tournamille et al., 1995).”
BackgroundInfluentialAvent, N. D., Martinez, A., Flegel, W. A., Olsson, M. L., Scott, M. L., Nogués, N., Písačka, M., Daniels, G. L., van der Schoot, C. E., Muñiz‐Díaz, E., et al. (2007) · Transfusion · doi:10.1111/j.1537-2995.2007.01309.x · Cited by 83
“The genetic basis of the Fy(a–b–) phenotype of people of African descent is unlike all other blood group polymorphisms and is caused by a promoter region mutation that disrupts a GATA-1 binding site.(23) This mutation abolishes the erythroid expression of the Fy glycoprotein, whereas it is expressed normally in nonery…”
BackgroundFasano, R. M., & Chou, S. T. (2016) · Transfusion Medicine Reviews · doi:10.1016/j.tmrv.2016.05.011 · Cited by 83
Plasmodium vivax Infections over 3 Years in Duffy Blood Group Negative Malians in Bandiagara, Mali
Niangaly, A., Gunalan, K., Ouattara, A., Coulibaly, D., Sá, J. M., Adams, M., Travassos, M. A., Ferrero, J., Laurens, M. B., Kone, A. K., et al. (2017) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.17-0254 · Cited by 81
“These Duffy negative infections were identified by the mutation of T to C in the GATA1-binding domain 59 to the open reading frame.(22) Other areas of Africa had P.”
BackgroundMethodInfluentialCXCR4 mutations in WHIM syndrome: a misguided immune system?
Diaz, G. A. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00226.x · Cited by 80
“DARC-negative status in the resistant African population results from a promoter mutation that specifically affects transcription in erythrocytes but not in other tissues ( 48 ).”
BackgroundPlasmodium vivax malaria in Duffy-negative individuals from Ethiopia
Woldearegai, T. G., Kremsner, P. G., Kun, J. F. J., & Mordmüller, B. G. (2013) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1093/trstmh/trt016 · Cited by 80
Castilho, L. M., Rios, M., Bianco, C., Pellegrino, J., Alberto, F., Saad, S. T. O., & Costa, F. F. (2002) · Transfusion · doi:10.1046/j.1537-2995.2002.00029.x · Cited by 82
Casanova, J., & Abel, L. (2020) · Human Genetics · doi:10.1007/s00439-020-02184-w · Cited by 84
Tung, J., Alberts, S. C., & Wray, G. A. (2010) · Trends in Genetics · doi:10.1016/j.tig.2010.05.005 · Cited by 79
The enigmatic mechanisms by which Plasmodium vivax infects Duffy-negative individuals
Popovici, J., Roesch, C., & Rougeron, V. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008258 · Cited by 84
“One single point mutation in the GATA-1 transcription factor binding site of the promoter of the gene at position −67 changing a T nucleotide to a C underlies the Duffy-negative phenotype [19, 24].”
BackgroundAfrican Americans with Asthma: Genetic Insights
Barnes, K. C., Grant, A. V., Hansel, N. N., Gao, P., & Dunston, G. M. (2007) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200607-146jg · Cited by 90
Hostetler, J. B., Lo, E. Y. Y., Kanjee, U., Amaratunga, C., Suon, S., Sreng, S., Mao, S., Yewhalaw, D., Mascarenhas, A. P., Kwiatkowski, D. P., et al. (2016) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0005091 · Cited by 78
Complex genetic control of susceptibility to malaria in mice
Fortin, A., Stevenson, M. M., & Gros, P. (2002) · Genes and Immunity · doi:10.1038/sj.gene.6363841 · Cited by 87
“A variant polymorphism at a GATA-1 binding site in the promoter of the DARC gene affects protein expression on erythrocytes and therefore modulates parasite entry into RBC and susceptibility to infection”
Backgroundde Brevern, A. G., Wong, H., Tournamille, C., Colin, Y., Kim, C. L. V., & Etchebest, C. (2005) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2005.05.016 · Cited by 81
Self-citationLeukocyte Chemoattractant Receptors in Human Disease Pathogenesis
Zabel, B. A., Rott, A., & Butcher, E. C. (2014) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-012513-104640 · Cited by 85
“The most common protective allele is a single-nucleotide polymorphism (SNP) in the promoter region of ACKR1 (position -46, T-to-C transition) that disrupts the consensus binding site for the erythroid-specific transcription factor GATA1 and leads to selective loss of ACKR1 on red blood cells (80).”
BackgroundXu, H., Lin, S., Zhou, Z., Li, D., Zhang, X., Yu, M., Zhao, R., Wang, Y., Qian, J., Li, X., et al. (2023) · Cellular and Molecular Immunology · doi:10.1038/s41423-023-01032-x · Cited by 85
“Deficiency of the GATA-1 binding site in the ACKR1/DARC promoter, which abolishes erythroid gene expression in Duffy-negative individuals, thus conferring resistance to Plasmodium vivax, was demonstrated to be the underlying mechanism [138, 139].”
BackgroundMichon, P., Woolley, I. J., Wood, E. M., Kastens, W., Zimmerman, P. A., & Adams, J. H. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02370-5 · Cited by 76
Lo, E. Y. Y., Yewhalaw, D., Zhong, D., Zemene, E., Degefa, T., Tushune, K., Ha, M., Lee, M., James, A. A., & Yan, G. (2015) · Malaria Journal · doi:10.1186/s12936-015-0596-4 · Cited by 79
“The Duffy antigen receptor for chemokines (DARC), also known as Fy glycoprotein, belongs to a family of silent heptahelical chemokine receptors [10].”
BackgroundThe Human Rh50 Glycoprotein Gene
Huang, C. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.4.2207 · Cited by 71
Verra, F., Mangano, V. D., & Modiano, D. (2009) · Parasite Immunology · doi:10.1111/j.1365-3024.2009.01106.x · Cited by 96
Plasmodium vivax in Africa: hidden in plain sight?
Rosenberg, R. (2007) · Trends in Parasitology · doi:10.1016/j.pt.2007.02.009 · Cited by 75
Tournamille, C., Kim, C. L. V., Gane, P., Blanchard, D., Proudfoot, A. E. I., Cartron, J., & Colin, Y. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.26.16274 · Cited by 73
Self-citationThe Duffy blood group system: a review
Meny, G. M. (2010) · Immunohematology · doi:10.21307/immunohematology-2019-202 · Cited by 74
Up-regulation of Duffy antigen receptor expression in children with renal disease
Liu, X., Hadley, T. J., Xu, L., Peiper, S. C., & Ray, P. E. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00385.x · Cited by 73
Basic Mechanisms of Hemolysis-Associated Thrombo-Inflammation and Immune Dysregulation
Dimitrov, J. D., Roumenina, L. T., Perrella, G., & Rayes, J. (2023) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.123.318780 · Cited by 78
Integration of red cell genotyping into the blood supply chain: a population-based study
Flegel, W. A., Gottschall, J. L., & Denomme, G. A. (2015) · The Lancet Haematology · doi:10.1016/s2352-3026(15)00090-3 · Cited by 71
A global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection
Andreakos, E., Abel, L., Vinh, D. C., Kaja, E., Drolet, B. A., Zhang, Q., O’Farrelly, C., Novelli, G., Rodríguez‐Gallego, C., Haerynck, F., et al. (2021) · Nature Immunology · doi:10.1038/s41590-021-01030-z · Cited by 75
Natural selection for the Duffy-null allele in the recently admixed people of Madagascar
Hodgson, J. A., Pickrell, J. K., Pearson, L. N., Quillen, E. E., Prista, A., Rocha, J., Soodyall, H., Shriver, M. D., & Perry, G. H. (2014) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.2014.0930 · Cited by 75
“The Duffy blood group locus (the DARC gene), for which phenotypic consequences are known for a genetic variant [5] that is strongly differentiated between sub-Saharan African and non-African human populations [6], and for which a credible selection pressure hypothesis exists [7], presents an excellent opportunity to e…”
BackgroundInfluentialGenetic basis of blood group diversity
Storry, J. R., & Olsson, M. L. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.05065.x · Cited by 73
Hopp, K. A., Weber, K. M., Bellissimo, D. B., Johnson, S. T., & Pietz, B. C. (2009) · Transfusion · doi:10.1111/j.1537-2995.2009.02377.x · Cited by 68
“Developments in molecular technology and accumulation of knowledge of the genetic polymorphisms responsible for defined blood group antigens in the past 20 years have made it possible to investigate the use of high-throughput molecular platforms as an enhancement to serologic typing of antigens.(1-10) In cases of limi…”
BackgroundGenetic epidemiology of health disparities in allergy and clinical immunology
Barnes, K. C. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.11.030 · Cited by 68
“The FY locus confers a strong selective advantage against malaria,(34) and the protective variant occurs in the majority of African individuals.(35) Thus it appears that positive selection has created a block of LD extending far greater than normal among Africans.”
BackgroundFunctional aspects of red cell antigens
Daniels, G. L. (1999) · Blood Reviews · doi:10.1016/s0268-960x(99)90020-6 · Cited by 68
Genetics of infectious disease resistance
Hill, A. V. S. (1996) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(96)80013-x · Cited by 69
Organization of the Human LU Gene and Molecular Basis of the Lua/Lub Blood Group Polymorphism
Nemer, W. E., Rahuel, C., Colin, Y., Gane, P., Cartron, J., & Kim, C. L. V. (1997) · Blood · doi:10.1182/blood.v89.12.4608 · Cited by 68
Self-citationDuffy antigen modifies the chemokine response in human endotoxemia
Mayr, F., Spiel, A. O., Leitner, J. M., Firbas, C., Kliegel, T., Jilma‐Stohlawetz, P., Derendorf, H., & Jilma, B. (2008) · Critical Care Medicine · doi:10.1097/01.ccm.0000297875.55969.db · Cited by 69
“The Duffy-negative phenotype in Africans is caused by a single T to C substitution at nucleotide 46, which disrupts the binding site for the GATA-1 erythroid transcription factor, resulting in a silent FY *B in the erythroid lineage but not in other tissues (22).”
BackgroundRogers, W. A., Salomone, J. R., Tacy, D. J., Camino, E. M., Davis, K. A., Rebeiz, M., & Williams, T. M. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003740 · Cited by 73
Evolution of a malaria resistance gene in wild primates
Tung, J., Primus, A. E., Bouley, A. J., Severson, T. F., Alberts, S. C., & Wray, G. A. (2009) · Nature · doi:10.1038/nature08149 · Cited by 68
High‐throughput multiplex PCR genotyping for 35 red blood cell antigens in blood donors
Jungbauer, C., Hobel, C., Schwartz, D. W. M., & Mayr, W. R. (2011) · Vox Sanguinis · doi:10.1111/j.1423-0410.2011.01542.x · Cited by 66
Yao, S., Hong, C., Ruiz-Narváez, E., Evans, S. S., Zhu, Q., Schaefer, B. A., Yan, L., Coignet, M. V., Lunetta, K. L., Sucheston‐Campbell, L. E., et al. (2018) · PLoS Genetics · doi:10.1371/journal.pgen.1007368 · Cited by 77
Ríos, Chaudhuri, Mallinson, Sausais, Gomensoro‐Garcia, Hannon, Rosenberger, Poole, Burgess, Pogo, et al. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.01882.x · Cited by 65
“Fya and Fyb are associated with a point mutation at nt 125 (respectively G and A) that encodes glycine or aspartic acid at residue 42 of the major form of the protein (Chaudhuri et al, 1995; Iwamoto et al, 1995; Mallinson et al, 1995a; Tournamille et al, 1995).”
BackgroundInfluentialCloning and characterization of human chemokine receptors
Power, C. A., & Wells, T. N. C. (1996) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(96)10019-5 · Cited by 65
TATA box polymorphisms in human gene promoters and associated hereditary pathologies
Savinkova, L. K., Ponomarenko, M. P., Пономаренко, П. М., Drachkova, I. A., Lysova, M. V., Arshinova, T., & Kolchanov, N. A. (2009) · Biochemistry (Moscow) · doi:10.1134/s0006297909020011 · Cited by 79
Kangelaris, K. N., Sapru, A., Calfee, C. S., Liu, K. D., Pawlikowska, L., Witte, J. S., Vittinghoff, E., Zhuo, H., Auerbach, A. D., Ziv, E., et al. (2011) · CHEST Journal · doi:10.1378/chest.11-1766 · Cited by 74
Zhang, S., Jouanguy, E., Zhang, Q., Abel, L., Puel, A., & Casanova, J. (2019) · Current Opinion in Immunology · doi:10.1016/j.coi.2019.03.008 · Cited by 67
Mendelian traits that confer predisposition or resistance to specific infections in humans
Pïcard, C., Casanova, J., & Abel, L. (2006) · Current Opinion in Immunology · doi:10.1016/j.coi.2006.05.005 · Cited by 71
Applications of DNA‐based assays in blood group antigen and antibody identification
Reid, M. E. (2003) · Transfusion · doi:10.1111/j.0041-1132.2003.00597.x · Cited by 72
Revisiting human primary immunodeficiencies
Casanova, J., Fieschi, C., Zhang, S., & Abel, L. (2008) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2008.01971.x · Cited by 69
Xu, H. J., Collins, J. F., Bai, L., Kiela, P. R., & Ghishan, F. K. (2001) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2001.280.3.c628 · Cited by 63
Age-Dependent Cellular Immune Responses to Plasmodium vivax Duffy Binding Protein in Humans
Xainli, J., Baisor, M., Kastens, W., Bockarie, M. J., Adams, J. H., & King, C. L. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.6.3200 · Cited by 63
Genome-wide association studies and susceptibility to infectious diseases
Newport, M. J., & Finan, C. (2011) · Briefings in Functional Genomics · doi:10.1093/bfgp/elq037 · Cited by 74
“vivax malaria [11,12].”
High‐throughput molecular profiling of blood donors for minor red blood cell and platelet antigens
Montpetit, A., Phillips, M. S., Mongrain, I., Lemieux, R., & St‐Louis, M. (2006) · Transfusion · doi:10.1111/j.1537-2995.2006.00805.x · Cited by 61
“For example, it is well known that a polymorphism in the promoter of the FY can block its expression.(21,22) This polymorphism is rare in white individuals, but extremely frequent in individuals of African descent.”
Background
Metadata
- Authors
- Tournamille, C., Colin, Y., Cartron, J. P., & Le Van Kim, C.
- Affiliations
- Inserm (FR)
- Venue
- Nature Genetics
- Published
- 1995-06
- Volume
- 10
- Issue
- 2
- Pages
- 224-228
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2080491517
- Cited by
- 741
- References
- 32
- Citations by year
- 2026: 15 · 2025: 14 · 2024: 23 · 2023: 28 · 2022: 20 · 2021: 28 · 2020: 27 · 2019: 23 · 2018: 22 · 2017: 27 · 2016: 21 · 2015: 22 · 2014: 25 · 2013: 33 · 2012: 25
- FWCI
- 20.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Health Sciences › Medicine › Hematology › Blood groups and transfusion
- Keywords
- Duffy blood group system, promoter mutations, erythroid gene expression, Plasmodium vivax, chemokine receptors, single-exon genes, African Americans
- MeSH terms
- Antigens, Protozoan, Base Sequence, Carrier Proteins, Chromosome Mapping, DNA-Binding Proteins, Duffy Blood-Group System, Erythrocytes, Genotype, Humans, Molecular Sequence Data, Mutation, Promoter Regions, Genetic, Receptors, Cell Surface, Transcription Factors, Transcription, Genetic, Tumor Cells, Cultured, Protozoan Proteins, Gene Expression, Black People, Erythroid-Specific DNA-Binding Factors, GATA1 Transcription Factor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.